Q4 2025 Earnings Call February 12, 2026 8:30 AM ESTCompany ParticipantsJoe KostkaFrank Laukien - Chairman, CEO ...
Welcome to the West Pharmaceutical Services' Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that today's conference is being recorded. I will now hand the conference ...
For the year, we grew adjusted EBITDA 11% to a record of more than $1.9 billion and expanded EBITDA margin by 30 basis points. Now that we are 1/3 of the way through our long-range plan, I remain ...
While we are confident our playbook will continue to drive results, we are reducing our full year outlook on the top line. This reflects reduced slower-than-expected progress in our North America ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results